Literature DB >> 28871405

[Survival after radical completion dissection or observation for sentinel node metastasis in melanoma].

Werner Hohenberger1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28871405     DOI： 10.1007/s00066-017-1200-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  3 in total

1.  Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.

Authors:  Ulrike Leiter; Rudolf Stadler; Cornelia Mauch; Werner Hohenberger; Norbert Brockmeyer; Carola Berking; Cord Sunderkötter; Martin Kaatz; Klaus-Werner Schulte; Percy Lehmann; Thomas Vogt; Jens Ulrich; Rudolf Herbst; Wolfgang Gehring; Jan-Christoph Simon; Ulrike Keim; Peter Martus; Claus Garbe
Journal:  Lancet Oncol       Date:  2016-05-05       Impact factor: 41.316

2.  Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.

Authors:  David Y Lee; Briana J Lau; Kelly T Huynh; Devin C Flaherty; Ji-Hey Lee; Stacey L Stern; Steve J O'Day; Leland J Foshag; Mark B Faries
Journal:  J Am Coll Surg       Date:  2016-01-29       Impact factor: 6.113

3.  Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harold J Hoekstra; Constantine P Karakousis; Christopher A Puleo; Brendon J Coventry; Mohammed Kashani-Sabet; B Mark Smithers; Eberhard Paul; William G Kraybill; J Gregory McKinnon; He-Jing Wang; Robert Elashoff; Mark B Faries
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245
  3 in total
  1 in total

Review 1.  Does It Really Pay-Off? Comparison of Lymphadenectomy versus Observational Approach in Skin Melanoma with Positive Sentinel Node Biopsy: Systematic Review and Meta-Analysis.

Authors:  Karolina Richter; Tomasz Stefura; Krzysztof Macheta; Jonasz Tempski; Jakub Kazoń; Magdalena Szeremeta; Paweł Klimont; Marta Kołodziej-Rzepa; Tomasz Wojewoda; Wojciech M Wysocki
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.